$0.23 Earnings Per Share Expected for Tilly’s Inc (TLYS) This Quarter

Share on StockTwits

Equities research analysts predict that Tilly’s Inc (NYSE:TLYS) will announce $0.23 earnings per share for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Tilly’s’ earnings, with estimates ranging from $0.22 to $0.24. Tilly’s posted earnings of $0.30 per share in the same quarter last year, which indicates a negative year over year growth rate of 23.3%. The business is scheduled to issue its next quarterly earnings report on Wednesday, December 5th.

On average, analysts expect that Tilly’s will report full year earnings of $0.90 per share for the current financial year, with EPS estimates ranging from $0.85 to $0.95. For the next financial year, analysts expect that the business will post earnings of $1.07 per share, with EPS estimates ranging from $0.95 to $1.14. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover Tilly’s.

Tilly’s (NYSE:TLYS) last issued its quarterly earnings results on Wednesday, August 29th. The specialty retailer reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.03. The company had revenue of $157.41 million during the quarter, compared to analysts’ expectations of $155.30 million. Tilly’s had a net margin of 4.41% and a return on equity of 15.08%. The business’s quarterly revenue was up 13.4% on a year-over-year basis. During the same period last year, the business earned ($0.11) EPS.

Several equities analysts have recently weighed in on the stock. Zacks Investment Research raised shares of Tilly’s from a “hold” rating to a “buy” rating and set a $23.00 price target for the company in a research note on Saturday, September 1st. William Blair raised shares of Tilly’s from a “market perform” rating to an “outperform” rating in a research note on Thursday, August 30th. Pivotal Research assumed coverage on shares of Tilly’s in a research note on Monday, August 13th. They set a “buy” rating and a $19.00 price target for the company. Roth Capital set a $22.00 price target on shares of Tilly’s and gave the stock a “buy” rating in a research note on Thursday, August 30th. Finally, B. Riley increased their price objective on Tilly’s from $17.00 to $26.00 and gave the company a “buy” rating in a report on Tuesday, September 4th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $23.25.

In other news, major shareholder Tilly Levine sold 10,000 shares of the stock in a transaction that occurred on Monday, July 16th. The stock was sold at an average price of $15.06, for a total value of $150,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Hezy Shaked sold 2,879,049 shares of the stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $18.50, for a total value of $53,262,406.50. The disclosure for this sale can be found here. In the last three months, insiders sold 5,503,521 shares of company stock valued at $101,639,714. 48.26% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bailard Inc. acquired a new stake in Tilly’s during the 2nd quarter valued at $597,000. Los Angeles Capital Management & Equity Research Inc. lifted its holdings in Tilly’s by 62.2% during the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 39,567 shares of the specialty retailer’s stock valued at $599,000 after purchasing an additional 15,170 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Tilly’s by 161.1% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 100,076 shares of the specialty retailer’s stock valued at $1,516,000 after purchasing an additional 61,750 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in Tilly’s by 1.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,217,093 shares of the specialty retailer’s stock valued at $13,753,000 after purchasing an additional 21,700 shares during the last quarter. Finally, Citadel Advisors LLC lifted its holdings in Tilly’s by 222.5% during the 2nd quarter. Citadel Advisors LLC now owns 19,225 shares of the specialty retailer’s stock valued at $291,000 after purchasing an additional 34,925 shares during the last quarter. 48.68% of the stock is owned by institutional investors.

Shares of TLYS traded up $0.51 during mid-day trading on Friday, hitting $16.70. 424,332 shares of the company’s stock were exchanged, compared to its average volume of 287,775. The stock has a market capitalization of $555.39 million and a P/E ratio of 25.69. Tilly’s has a 52 week low of $10.72 and a 52 week high of $25.46.

About Tilly’s

Tilly's, Inc retails casual apparel, footwear, and accessories for young men and women, and boys and girls in the United States. Its apparel merchandise includes tops, outerwear, bottoms, and dresses; and accessories merchandise comprises backpacks, hats, sunglasses, headphones, handbags, watches, jewelry, and others.

Read More: What is the Dow Jones Industrial Average (DJIA)?

Get a free copy of the Zacks research report on Tilly’s (TLYS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tilly`s (NYSE:TLYS)

Receive News & Ratings for Tilly's Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilly's and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

$0.23 Earnings Per Share Expected for Tilly’s Inc  This Quarter
$0.23 Earnings Per Share Expected for Tilly’s Inc This Quarter
Analysts Expect Strongbridge Biopharma plc  Will Announce Quarterly Sales of $5.48 Million
Analysts Expect Strongbridge Biopharma plc Will Announce Quarterly Sales of $5.48 Million
Brokerages Set Stoneridge, Inc.  Target Price at $31.00
Brokerages Set Stoneridge, Inc. Target Price at $31.00
Amneal Pharmaceuticals Inc  Receives Consensus Recommendation of “Hold” from Analysts
Amneal Pharmaceuticals Inc Receives Consensus Recommendation of “Hold” from Analysts
Bitstar  Reaches Market Cap of $197,456.00
Bitstar Reaches Market Cap of $197,456.00
Deutsche eMark Market Capitalization Hits $274,893.00
Deutsche eMark Market Capitalization Hits $274,893.00


Leave a Reply

© 2006-2018 Ticker Report. Google+.